Novel anti-cancer agents based on germacrone: design, synthesis, biological activity, docking studies and MD simulations

Germacrone is a major activity component found in Curcuma zedoaria oil product, which is extracted from Curcuma zedoaria . In the present study, novel germacrone derivatives were first designed based on the theories of bioalkylating agents, synthesized, and then investigated for their inhibition eff...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:RSC advances 2017, Vol.7 (7), p.3760-3767
Hauptverfasser: Ye, Lianbao, Wu, Jie, Chen, Weiqiang, Feng, Yu, Shen, Zhibing
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3767
container_issue 7
container_start_page 3760
container_title RSC advances
container_volume 7
creator Ye, Lianbao
Wu, Jie
Chen, Weiqiang
Feng, Yu
Shen, Zhibing
description Germacrone is a major activity component found in Curcuma zedoaria oil product, which is extracted from Curcuma zedoaria . In the present study, novel germacrone derivatives were first designed based on the theories of bioalkylating agents, synthesized, and then investigated for their inhibition effects on Bel-7402, HepG2, A549, and HeLa cells. Moreover, the study also evaluated the inhibition of these derivatives on c-Met kinase, which is expressed in a number of cancers. The results indicated that most of the compounds showed a stronger inhibitory effect on cancer cells and c-Met kinase than germacrone. Besides these findings, molecular docking studies were also carried out to analyze the results and explain the molecular mechanism of activities to c-Met kinase. Molecular dynamics simulations have been carried out for the further evaluation of binding stabilities between the compounds and their receptors.
doi_str_mv 10.1039/C6RA26944C
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1039_C6RA26944C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1039_C6RA26944C</sourcerecordid><originalsourceid>FETCH-LOGICAL-c267t-f06c7178f4c0d15e470e8e1ed21183a9d6e71c77a5afac155443931438251a083</originalsourceid><addsrcrecordid>eNpNkFFLwzAUhYMoOOZe_AV5llWTJk1a30Z1KkwF0eeSJbc12iXSmw33760o6Hk55-mD8xFyytk5Z6K6qNXTIleVlPUBmeRMqixnqjr8t4_JDPGNjVEFzxWfkM-HuIOempB8Zk2wMFDTQUhI1wbB0RhoB8PG2CEGuKQO0HdhTnEf0uu4cU7XPvax89aMFJv8zqf9nLpo333oKKat84Aj39H7K4p-s-1N8jHgCTlqTY8w--0peVleP9e32erx5q5erDKbK52ylimruS5baZnjBUjNoAQOLue8FKZyCjS3WpvCtMbyopBSVIJLUeYFN6wUU3L2wx0fIA7QNh-D35hh33DWfGtr_rSJL2L5YF8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Novel anti-cancer agents based on germacrone: design, synthesis, biological activity, docking studies and MD simulations</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Ye, Lianbao ; Wu, Jie ; Chen, Weiqiang ; Feng, Yu ; Shen, Zhibing</creator><creatorcontrib>Ye, Lianbao ; Wu, Jie ; Chen, Weiqiang ; Feng, Yu ; Shen, Zhibing</creatorcontrib><description>Germacrone is a major activity component found in Curcuma zedoaria oil product, which is extracted from Curcuma zedoaria . In the present study, novel germacrone derivatives were first designed based on the theories of bioalkylating agents, synthesized, and then investigated for their inhibition effects on Bel-7402, HepG2, A549, and HeLa cells. Moreover, the study also evaluated the inhibition of these derivatives on c-Met kinase, which is expressed in a number of cancers. The results indicated that most of the compounds showed a stronger inhibitory effect on cancer cells and c-Met kinase than germacrone. Besides these findings, molecular docking studies were also carried out to analyze the results and explain the molecular mechanism of activities to c-Met kinase. Molecular dynamics simulations have been carried out for the further evaluation of binding stabilities between the compounds and their receptors.</description><identifier>ISSN: 2046-2069</identifier><identifier>EISSN: 2046-2069</identifier><identifier>DOI: 10.1039/C6RA26944C</identifier><language>eng</language><ispartof>RSC advances, 2017, Vol.7 (7), p.3760-3767</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c267t-f06c7178f4c0d15e470e8e1ed21183a9d6e71c77a5afac155443931438251a083</citedby><cites>FETCH-LOGICAL-c267t-f06c7178f4c0d15e470e8e1ed21183a9d6e71c77a5afac155443931438251a083</cites><orcidid>0000-0002-7885-7528</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,4022,27921,27922,27923</link.rule.ids></links><search><creatorcontrib>Ye, Lianbao</creatorcontrib><creatorcontrib>Wu, Jie</creatorcontrib><creatorcontrib>Chen, Weiqiang</creatorcontrib><creatorcontrib>Feng, Yu</creatorcontrib><creatorcontrib>Shen, Zhibing</creatorcontrib><title>Novel anti-cancer agents based on germacrone: design, synthesis, biological activity, docking studies and MD simulations</title><title>RSC advances</title><description>Germacrone is a major activity component found in Curcuma zedoaria oil product, which is extracted from Curcuma zedoaria . In the present study, novel germacrone derivatives were first designed based on the theories of bioalkylating agents, synthesized, and then investigated for their inhibition effects on Bel-7402, HepG2, A549, and HeLa cells. Moreover, the study also evaluated the inhibition of these derivatives on c-Met kinase, which is expressed in a number of cancers. The results indicated that most of the compounds showed a stronger inhibitory effect on cancer cells and c-Met kinase than germacrone. Besides these findings, molecular docking studies were also carried out to analyze the results and explain the molecular mechanism of activities to c-Met kinase. Molecular dynamics simulations have been carried out for the further evaluation of binding stabilities between the compounds and their receptors.</description><issn>2046-2069</issn><issn>2046-2069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpNkFFLwzAUhYMoOOZe_AV5llWTJk1a30Z1KkwF0eeSJbc12iXSmw33760o6Hk55-mD8xFyytk5Z6K6qNXTIleVlPUBmeRMqixnqjr8t4_JDPGNjVEFzxWfkM-HuIOempB8Zk2wMFDTQUhI1wbB0RhoB8PG2CEGuKQO0HdhTnEf0uu4cU7XPvax89aMFJv8zqf9nLpo333oKKat84Aj39H7K4p-s-1N8jHgCTlqTY8w--0peVleP9e32erx5q5erDKbK52ylimruS5baZnjBUjNoAQOLue8FKZyCjS3WpvCtMbyopBSVIJLUeYFN6wUU3L2wx0fIA7QNh-D35hh33DWfGtr_rSJL2L5YF8</recordid><startdate>2017</startdate><enddate>2017</enddate><creator>Ye, Lianbao</creator><creator>Wu, Jie</creator><creator>Chen, Weiqiang</creator><creator>Feng, Yu</creator><creator>Shen, Zhibing</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-7885-7528</orcidid></search><sort><creationdate>2017</creationdate><title>Novel anti-cancer agents based on germacrone: design, synthesis, biological activity, docking studies and MD simulations</title><author>Ye, Lianbao ; Wu, Jie ; Chen, Weiqiang ; Feng, Yu ; Shen, Zhibing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c267t-f06c7178f4c0d15e470e8e1ed21183a9d6e71c77a5afac155443931438251a083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ye, Lianbao</creatorcontrib><creatorcontrib>Wu, Jie</creatorcontrib><creatorcontrib>Chen, Weiqiang</creatorcontrib><creatorcontrib>Feng, Yu</creatorcontrib><creatorcontrib>Shen, Zhibing</creatorcontrib><collection>CrossRef</collection><jtitle>RSC advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ye, Lianbao</au><au>Wu, Jie</au><au>Chen, Weiqiang</au><au>Feng, Yu</au><au>Shen, Zhibing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel anti-cancer agents based on germacrone: design, synthesis, biological activity, docking studies and MD simulations</atitle><jtitle>RSC advances</jtitle><date>2017</date><risdate>2017</risdate><volume>7</volume><issue>7</issue><spage>3760</spage><epage>3767</epage><pages>3760-3767</pages><issn>2046-2069</issn><eissn>2046-2069</eissn><abstract>Germacrone is a major activity component found in Curcuma zedoaria oil product, which is extracted from Curcuma zedoaria . In the present study, novel germacrone derivatives were first designed based on the theories of bioalkylating agents, synthesized, and then investigated for their inhibition effects on Bel-7402, HepG2, A549, and HeLa cells. Moreover, the study also evaluated the inhibition of these derivatives on c-Met kinase, which is expressed in a number of cancers. The results indicated that most of the compounds showed a stronger inhibitory effect on cancer cells and c-Met kinase than germacrone. Besides these findings, molecular docking studies were also carried out to analyze the results and explain the molecular mechanism of activities to c-Met kinase. Molecular dynamics simulations have been carried out for the further evaluation of binding stabilities between the compounds and their receptors.</abstract><doi>10.1039/C6RA26944C</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-7885-7528</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2046-2069
ispartof RSC advances, 2017, Vol.7 (7), p.3760-3767
issn 2046-2069
2046-2069
language eng
recordid cdi_crossref_primary_10_1039_C6RA26944C
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
title Novel anti-cancer agents based on germacrone: design, synthesis, biological activity, docking studies and MD simulations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T18%3A01%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20anti-cancer%20agents%20based%20on%20germacrone:%20design,%20synthesis,%20biological%20activity,%20docking%20studies%20and%20MD%20simulations&rft.jtitle=RSC%20advances&rft.au=Ye,%20Lianbao&rft.date=2017&rft.volume=7&rft.issue=7&rft.spage=3760&rft.epage=3767&rft.pages=3760-3767&rft.issn=2046-2069&rft.eissn=2046-2069&rft_id=info:doi/10.1039/C6RA26944C&rft_dat=%3Ccrossref%3E10_1039_C6RA26944C%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true